Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


BHP Billiton Named UCL Enterprise Partner of the Year 2012

18 June 2012

BHP Billiton have been named UCL Enterprise Partner of the Year in recognition of their strong collaborative work with UCL. This follows the agreement signed in June 2011 to establish Institutes in London and Adelaide.

The two new institutes will drive research into the complex economic, legal, environmental, technological and cultural issues faced by the resources sector and provide a framework within which expertise from the northern and southern hemispheres can be shared and innovative responses developed.